An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration

Published Oct 24, 2012Experimental eye research

Link between transferrin gene differences, blood transferrin levels, and age-related macular degeneration

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Page updated Apr 6, 2026

Abstract

Advanced age and a family history of AMD may be independent risk factors for age-related macular degeneration.

The GG genotype of the rs4481157 polymorphism is associated with a decreased risk of dry AMD (OR 0.50; p < 0.05).
The GA genotype of the rs4481157 polymorphism may increase the risk of dry AMD (OR 1.07; p < 0.05) and decrease the risk of progression to the wet form (OR 0.63; p < 0.05).
Gene-environment interactions indicate that the rs4481157 polymorphism may modulate AMD risk among obese individuals.
A moderate association between the rs4481157 polymorphism and AMD risk was observed in former smokers, with a stronger association in current smokers.
Serum transferrin levels were significantly higher in the AMD group compared to the control group (p < 0.001), while total serum iron levels did not differ.
Serum transferrin levels are associated with the rs8177178 (p < 0.001) and rs4481157 (p < 0.01) polymorphisms.

AI simplified

Age-related macular degeneration (AMD) is a degenerative disease of the eye, triggered by the damage of the macular cells. In the Western world it is the most frequent cause of blindness in the elderly. Oxidative stress is proved to play a key role in AMD pathogenesis and since iron accumulation has been found in AMD maculas, it may accelerate the oxidative processes in this tissue. In the present work we investigated the association between four polymorphisms of the transferrin gene (rs8177178; rs8177179; rs4481157; rs1130459) and AMD in dependence on the transferrin protein and iron serum levels. We employed PCR-RFLP (polymerase chain reaction - restriction fragment length polymorphism) for genotype determination, ELISA assay for serum transferrin evaluation and colorimetric assay for measurement of iron concentration in the serum. We found that advanced age and AMD family history may be independent risk factors for AMD (1.02, p < 0.05 and 8.88, p < 0.001, respectively). At the rs4481157 site The GG genotype of the rs4481157 polymorphism decreased the risk of dry AMD (OR 0.50; p < 0.05), while the GA increased this risk (OR 1.07; p < 0.05). Moreover, the GA genotype of this polymorphism decreased the risk of progression to the wet form (OR 0.63; p < 0.05). The analysis of the gene-environment interactions showed that the rs4481157 polymorphism modulates the AMD risk among obese (BMI above 30) individuals. In the former smokers group we observed a moderate association between rs4481157 polymorphism and AMD risk while this association in current smokers was stronger. We found also that the serum level of transferrin was higher in the AMD group (p < 0.001) than in the control, but the total serum iron levels did not differ between both groups. We found that the serum transferrin was associated with the rs8177178 (p < 0.001) and rs4481157 (p < 0.01) polymorphisms, and the common variant (GG) of both sites was related to a lower level of transferrin. Presented data may contribute to the involvement of iron homeostasis in AMD risk.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief